ÂÜÀòÂÒÂ×

Neelanjan Bose, Ph.D. has a diverse work experience spanning multiple companies and research areas. Neelanjan'scurrent role is as a Scientist II at DICE Therapeutics, where they serve as a DMPK project representative for small discovery and development programs in the immunology and autoimmune disease field. Neelanjan'sresponsibilities include performing in vitro drug metabolism studies.

Prior to DICE Therapeutics, Dr. Bose worked as a Senior Scientist at Emery Pharma, where they oversaw bioanalytical projects conducted under R&D and GLP/cGMP guidance. Neelanjan utilized various analytical techniques such as HPLC, mass spectrometry, and NMR for drug modalities, metabolites, impurities, and biomarkers. Neelanjan was involved in both internal therapeutic and client-based discovery and development programs.

Dr. Bose's research experience also includes postdoctoral positions at UCSF and the Buck Institute for Research on Aging. At UCSF, they focused on understanding and developing drugs for metabolic disorders, primarily in diabetes, neurodegenerative, and kidney stone diseases. Neelanjan'sachievements include establishing an LC-HRMS-based metabolomics platform for metabolite and biomarker discovery in urolithiasis and engaging in multidisciplinary collaborations. At the Buck Institute, they developed mass spectrometry-based assays to study diseases related to aging and metabolism, specifically investigating the pathological consequences of elevated advanced glycation end-products.

During their time as a graduate student at Cornell University, Dr. Bose conducted research on the identification of small-molecule signals that regulate development in nematodes using techniques from analytical chemistry and chemical biology. Neelanjan'swork involved analyzing complex nematode metabolomes and developing new strategies for profiling. Neelanjan also gained internship experience at the Saha Institute of Nuclear Physics.

Overall, Dr. Bose's work experience showcases their expertise in drug metabolism, bioanalytical research, metabolic disorders, and signaling molecule identification.

Neelanjan Bose, Ph.D., completed their education in a chronological order. Neelanjan started their academic journey by obtaining a High School Diploma from Ramakrishna Mission Vidyalaya, Narendrapur, in the years 1995-2003. Neelanjan then pursued higher education at Presidency College, University of Calcutta, Kolkata, India, where they earned a Bachelor of Science (B.Sc.) degree in Chemistry from 2003 to 2006. Neelanjan further continued their studies at the Indian Institute of Technology, Kanpur, from 2006 to 2008, where they obtained a Master of Science (M.Sc.) degree in Chemistry. Finally, they completed their highest level of education at Cornell University from 2008 to 2013, earning a Doctor of Philosophy (Ph.D.) in Analytical Chemistry and Chemical Biology.